$ONC
BeOne Medicines Ltd.
Nasdaq · Healthcare · Pharmaceutical Preparations · Basel
ONC chart
What traders are saying about $ONC
Latest postsBeOne Medicines Ltd. news
- BeOne Medicines Ltd. - Sponsored ADR (NASDAQ:ONC) Stock Rated "Buy" by Wall Street Analysts
MarketBeat ·
- Is BeOne Medicines (ONC) Undervalued After ESMO Survival Data Strengthened Its Oncology Case?
Simply Wall Street ·
- BeOne Medicines presents new data across solid tumor disease areas at ESMO 2026
TipRanks ·
- BeOne Medicines AG (ONC) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- BeOne Medicines Ltd. - Sponsored ADR $ONC Position Trimmed by Crossmark Global Holdings Inc.
MarketBeat ·
- 3 Oncology Stocks To Watch After Small Cell Lung Cancer Trial Results
Simply Wall Street ·
- BeOne Reports 36% Response Rate for Liver Cancer Drug in Phase 1
TOKENPOST ·
- 3 Healthcare Stocks To Watch In October 2026
Yahoo Finance ·
- BeOne Medicines (ONC) Could Be 13% Undervalued As ESMO Data Lifts The Narrative
Yahoo Finance ·
- BeOne Medicines (ONC) Brought Fresh ESMO 2026 Solid Tumor Data Into Focus
Simply Wall Street ·
- BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 2026
Yahoo Finance ·
- An experimental lung cancer drug shrank tumors in 56% of patients whose tumors had high marker levels.
Stock Titan ·
BeOne Medicines Ltd. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $5.34B | $3.81B | $2.46B | $1.42B |
| Net income | $286.9M | -$644.8M | -$881.7M | -$2.00B |
| Diluted EPS | $0.19 | $-0.47 | $-0.65 | $-1.49 |
| Total assets (year end) | $8.19B | $5.92B | $5.81B | $6.38B |
| Cash and equivalents (year end) | $4.55B | $2.63B | $3.17B | $3.87B |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About BeOne Medicines Ltd.
- Ticker
- ONC (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Basel
- Fiscal year end
- December 31
- SEC CIK
- 1651308
- Former names
- BeiGene, Ltd.
Frequently asked questions
What exchange is BeOne Medicines Ltd. listed on?
BeOne Medicines Ltd. trades on the Nasdaq under the ticker symbol ONC.
What industry is BeOne Medicines Ltd. in?
BeOne Medicines Ltd. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is BeOne Medicines Ltd. headquartered?
BeOne Medicines Ltd.'s business address on file with the SEC is in Basel.
When does BeOne Medicines Ltd.'s fiscal year end?
BeOne Medicines Ltd.'s fiscal year ends on December 31.
How much revenue did BeOne Medicines Ltd. report?
BeOne Medicines Ltd. reported $5.34B in revenue for calendar year 2025, according to its SEC filings.